EGFR+ adenocarcinoma of lung currently on clinical trial with Pembrolizumab and Pegazo Hyaluronidase inhibitor with bone and liver mets. Continue to monitor for toxicity per protocol 2. Lower back pain, BLE pain, and lower abdominal pain related to malignancy. 3. Nausea/vomiting: patient had emesis x 2 today. Finds relief with Zofran. 4. Constipation: Senna and Miralax ordered. 5. Hypothyroidism, I recommend continue on Levothyroxine 6. Hypocalcemia, I recommend continue on Cholecalciferol Patient is stable and otherwise doing well on trial. Pain management priority at this time
[Solved]: EGFR+ adenocarcinoma of lung currently on clinical…
Need help with your Pain Management & Analgesics case study or NCLEX preparation? Connect with a verified Nursing expert now.
